Charles Schwab Investment Management Inc Compass Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 273,472 shares of CMPX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,472
Previous 297,880
8.19%
Holding current value
$1.14 Million
Previous $565,000
25.84%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CMPX
# of Institutions
105Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$63.3 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$56.1 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$41.7 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$29.7 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$27.5 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $421M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...